Fut, nem toborozFázis nélkül
INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE
A legfontosabb adatok
- Ki végzi
- Brixton Biosciences, Inc.
- Hol
- Boston, Chicago, Edmond, Flint, Gainesville, Houston, Johns Creek, Larkspur, New Orleans, North Bethesda, San Antonio, Sewickley, Tulsa, Washington D.C. és Wichita (Egyesült Államok)Mind a 15 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 263 fő, tervezett
- Kezdés
- 2024. nov. 19.
- Várható befejezés
- 2027. febr. 1.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Neural Ice
- Triamcinolone acetate
- A regiszteradat frissítve
- 2025. október 28.
Ki vehet részt
- Életkor
- 22 év – 80 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 30 feltétel megnézéseKevesebb
Ki vehet részt
- Age 22 to 80, inclusive of any gender
- Baseline pain intensity of >/= 5 of the Numeric Rating Scale (NRS) despite current treatment Confidential Brixton Biosciences Inc. Page 12 of 53 Version: 1.1, 30 August 2024
- Chronic symptomatic osteoarthritis of the knee (K-L stage 2, 3, or 4) on plain x-rays obtained within the previous 12 months
- At least 3 months of previous conservative treatments (NSAID, acetaminophen, physical therapy, cortisone injections) that are not currently providing relief
- Agree to see one doctor (study investigator) for knee pain during the study period
- Willing/able to understand the informed consent form and provide written informed consent
- Able to complete outcome measures (including electronic patient reported outcome measures)
Ki nem vehet részt
- Currently taking >60 MME/day, as determined per MDcalc.com (opioid conversion calculator)
- Any condition or circumstance that would impact or confound assessment of safety and/or pain. For example, comorbid or concomitant pain conditions, pre-existing lower limb neurologic deficits, any psychiatric or neurologic disease
- Participation in any clinical study of a therapeutic investigational product within 30 days prior to enrollment
- Known allergy to glycerol, hyaluronic acid, poloxamer 407, or phosphate buffered saline
- History of cryoglobulinemia
- History of cold-induced auto-immune hemolytic anemia (e.g. paroxysmal cold hemoglobinuria or cold agglutinin disease)
- History of cold urticaria
- History of Chilblain's (pernio) disease in the lower extremities
- History of Raynaud's disease
- Open and/or infected wounds or active tumor at or near the treatment site
- History of vascular surgery involving femoral vessels on the injection side
- History of surgical procedures to affected limb that, in the opinion of the investigator, could have impacted the integrity of the genicular nerves or blood vessels
- Active bacterial or fungal infection that at the discretion of the investigator would preclude study participation
- History of History of systemic inflammatory conditions such as rheumatoid arthritis
- Bleeding disorders anticoagulant therapy, unless appropriately stopped or reversed for the procedure
- Any condition (such as history of significant cardiovascular, renal failure/dialysis, hepatic or other systemic comorbidity/chronic pain condition) or circumstance that, in the opinion of the investigator, would compromise the safety of the subject or the quality of study data
- Use of intra-articular injection of corticosteroid within the previous 3 months, or hyaluronic acid, prolotherapy, Confidential Brixton Biosciences Inc. Page 13 of 53 Version: 1.1, 30 August 2024 autologous blood, or platelet rich plasma injections for the index knee within the previous 6 months
- Cryoneurolysis, thermal or pulsed radiofrequency ablation, or phenol injection for the index knee within the past 12 months
- Known contraindication to use of a regional anesthetic block
- Pregnant, nursing or intent of becoming pregnant during the study period
- Body habitus/knee anatomy that would preclude the use of the product injection needle size
- Unwilling to refrain from participation in any other clinical study through the duration of this study
- Unwilling to refrain from any scheduled surgeries during the duration of this study
Helyszínek itt: Egyesült Államok
- Brigham and Women's HospitalBoston, Egyesült Államok
- Insight Hospital and Medical Center ChicagoChicago, Egyesült Államok
- Clinical Investigations, LLCEdmond, Egyesült Államok
- Insight Research InstituteFlint, Egyesült Államok
- The Orthopaedic InstituteGainesville, Egyesült Államok
- NextStage Clinical Research All-American Orthopedic & Sports Medicine InstituteHouston, Egyesült Államok
- Emory UniversityJohns Creek, Egyesült Államok
- Marin HealthLarkspur, Egyesült Államok
- Ochsner Health SystemNew Orleans, Egyesült Államok
- NextStage Clinical Research Regenerative Orthopedics and Sports MedicineNorth Bethesda, Egyesült Államok
- UT San AntonioSan Antonio, Egyesült Államok
- Pain Diagnostics and Interventional CareSewickley, Egyesült Államok
- NextStage Clinical Research The Orthopedic CenterTulsa, Egyesült Államok
- Centers for Advanced OrthopedicsWashington D.C., Egyesült Államok
- NextStage Clinical Research Advanced Orthopaedic AssociatesWichita, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
A vizsgálat 2 csoportja
- Neural Ice injectionsA vizsgált kezelés
This therapy will be injected around the superolateral, superomedial, and inferomedial genicular nerves.
Kezelés: Neural Ice
- Corticosteroid injectionMár használt kezelés, összehasonlításként
Intraarticular corticosteroid injection is defined as a single dose of Triamcinolone 40mg injected directly into the joint space.
Kezelés: Triamcinolone acetate
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE: A MULTI-CENTER, RANDOMIZED, CONTROLLED STUDY (ICE STUDY)
- A regiszteradat frissítve
- 2025. október 28.